Foresite Capital

Foresite Capital

Larkspur, Californiaforesitecapital.com

Overview

Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles. They use a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. The firm focuses on breakthrough opportunities at the intersection of tech and biotech, with a deeply technical investment team.

Year Founded

2011

AUM

$3.5B

Portfolio Companies

86

Investments

CompanyDateStageLead
Obsidian TherapeuticsApr 2026Private PlacementCo-investor
Pinnacle MedicinesMar 2026Series BLead
Candid TherapeuticsMar 2026PIPECo-investor
Slate MedicinesFeb 2026Series ALead
Korsana BiosciencesFeb 2026SeedCo-investor

Key People

Cynthia Carpenter

Executive Associate To CEO And Founder, Jim Tananbaum

Jim Tananbaum

Founder And CEO

Cindy Xiong

Partner

Hyung Chun

Partner

Beata Lewandowska

Vice President Partner

Shoman Kasbekar

Principal

Matt Dyer 🇺🇦

Executive Advisor Investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLarkspur, California
Year Founded2011
AUM$3.5B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.